Role of lipids and inflammasome gene polymorphisms in type 1 diabetes脂质和炎性小体基因多态性在1型糖尿病中的作用EGYPTIAN JOURNAL OF PEDIATRIC ALLERGY AND IMMUNOLOGYIF02025-10-010PRE
In vitro antitumor effects of methanolic extracts of three Ganoderema mushroomsSCIENTIFIC REPORTSIF3.92025-01-170OAAI
Smart chitosan nanogel for targeted doxorubicin delivery, ensuring precise release, and minimizing side effects in Ehrlich ascites carcinoma-bearing miceINTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULESIF8.52024-05-017PRE
Experimental and computational studies of silver(I) dibenzoylmethane-based complexes, interaction with DNA/RNA/BSA biomolecules, and in vitro cytotoxic activityJOURNAL OF INORGANIC BIOCHEMISTRYIF3.22023-04-019PRE
Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin deliveryINTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULESIF8.52022-06-0136OAAI
Synthesis, characterization, DNA binding/cleavage, cytotoxic, apoptotic, and antibacterial activities of V(IV), Mo(VI), and Ru(II) complexes containing a bioactive ONS-donor chelating agentAPPLIED ORGANOMETALLIC CHEMISTRYIF02020-11-1518PREAI
Metal-organic frameworks as efficient materials for drug delivery: Synthesis, characterization, antioxidant, anticancer, antibacterial and molecular docking investigationAPPLIED ORGANOMETALLIC CHEMISTRYIF02020-06-26139PREAI
Oncostatic treatment effect of triple negative breast cancer cell line with copper (I)-nicotinate complexJOURNAL OF CELLULAR BIOCHEMISTRYIF2.82018-10-268PREAI
Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian PatientsANNALS OF HEPATOLOGYIF4.42017-11-013OAAI
Synthesis, spectral characterization and anticancer studies of three novel ruthenium(III) 2,2-bipyridine complexesAPPLIED ORGANOMETALLIC CHEMISTRYIF02015-03-234PREAI
Discriminant function based on hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhotic from non-cirrhotic liver diseased patients in chronic HCV infectionCLINICA CHIMICA ACTAIF2.92006-07-0123PREAI